Cambridge Crystallographic Data Centre (CCDC)

Understanding compound selectivity with data-driven drug design

This article is brought to you by: 

Selectivity is a crucial property in the development of new active pharmaceutical ingredients (APIs). Binding site comparisons within a protein family are key to modulating the selectivity profile of a potential new API, which includes understanding both on- and off-target effects. This white paper outlines the importance of data-driven-drug design to maximise compound selectivity.

CSD Solid Form Suite

The Cambridge Crystallographic Data Centre (CCDC) has announced CSD Solid Form Suite to support pharmaceutical and agrochemical development

Subscribe to RSS - Cambridge Crystallographic Data Centre (CCDC)